Orr Patty M, McGinnis Matthew A, Hudson Laurel R, Coberley Sadie S, Crawford Albert, Clarke Janice L, Goldfarb Neil I
Healthways, Inc., Nashville, Tennessee 37215, USA.
Dis Manag. 2006 Oct;9(5):277-83. doi: 10.1089/dis.2006.9.277.
Compliance with hemoglobin A1c (A1c) testing is suboptimal despite the clear national recommendations and guidelines established for care of patients with diabetes. Recent studies have demonstrated a relationship between participation in a diabetes disease management (DM) program and improved adherence to A1c testing. A focused intervention study was initiated to investigate the ability of a DM program to drive improvement in A1c testing. A cohort of 36,327 members experienced a statistically significant increase (29%) in A1c testing while participating in the 6-month focused intervention. This finding demonstrated that a focused DM intervention is able to deliver improvement in a clinical process metric critical for managing patients with diabetes, thereby reducing their risk of disease exacerbation.
尽管针对糖尿病患者护理制定了明确的国家建议和指南,但血红蛋白A1c(A1c)检测的依从性仍不理想。最近的研究表明,参与糖尿病疾病管理(DM)计划与提高A1c检测的依从性之间存在关联。一项针对性的干预研究启动,以调查DM计划推动A1c检测改善的能力。在参与为期6个月的针对性干预期间,36327名成员的队列中,A1c检测出现了具有统计学意义的显著增加(29%)。这一发现表明,针对性的DM干预能够在对糖尿病患者管理至关重要的临床过程指标上带来改善,从而降低他们疾病恶化的风险。